We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Molecular Diagnostics

Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

An RNA-based test integrating tumor-immune signals predicts NSCLC immunotherapy response. More...
19 Oct 2026
Image: Shield is a blood-based CRC screening test that uses methylation partitioning cell-free DNA (mp-cfDNA) technology to detect colorectal cancer-associated alterations (Photo courtesy of Guardant Health, Inc.)

Modeling Study Shows Blood-Based CRC Screening Could Prevent More Deaths Than Stool Tests

New data show a blood-based colorectal cancer ( screening test boosts adherence and colonoscopy uptake. More...
19 Oct 2026
DB function failed with error number 0

Genomic Tool Supports Analysis of Repeat Expansions Linked to Inherited Disorders

More...
18 Oct 2026
DB function failed with error number 0

Managed Care Report Examines Barriers to Breast Cancer Biomarker Testing

More...
17 Oct 2026
Image: Supervised learning facilitates the generation of an STXBP1-specific variant effect predictor, EpiPred. (Jeffrey D. Calhoun et al., Gene-specific machine learning model EpiPred identifies likely pathogenic variants in the epilepsy-related gene STXBP1, Journal of Clinical Investigation (2026). DOI: 10.1172/jci207160)

AI Tool Classifies Pathogenic Variants in Severe Childhood Epilepsy

An AI approach predicts whether genetic variants cause disease, outperforming general tools and helping clarify uncertain epilepsy findings More...
16 Oct 2026
Image Credit: iStock

Noninvasive Cervical Test Detects Endometrial Cancer for Triage

A new cervical methylation test enables noninvasive triage for endometrial cancer. More...
16 Oct 2026
Image: EndoSign is a non-endoscopic, methylation-based Barrett’s esophagus test using samples collected with an FDA-cleared EndoSign Cell Collection Device (Photo courtesy of Cyted Health)

Molecular Test Detects Barrett’s Esophagus to Guide Endoscopy Referral

A new non-endoscopic methylation test flags Barrett’s esophagus, guiding endoscopy with 90% sensitivity and 86% specificity. More...
16 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Neonatal Heel Incision Device
Tenderfoot


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.